mitoxantrone has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ujhelly, O | 1 |
| Ozvegy, C | 1 |
| Várady, G | 1 |
| Cervenak, J | 1 |
| Homolya, L | 1 |
| Grez, M | 1 |
| Scheffer, G | 1 |
| Roos, D | 1 |
| Bates, SE | 1 |
| Váradi, A | 1 |
| Sarkadi, B | 1 |
| Német, K | 1 |
1 other study available for mitoxantrone and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells.
Topics: Antigens, CD34; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transp | 2003 |